According to Evoke Pharma 's latest financial reports the company's current EPS (TTM) is -โน202.05. In 2022 the company made an earnings per share (EPS) of -โน226.02 an increase over its 2021 EPS that were of -โน269.68.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -โน193.72 | -14.29% |
2022 | -โน226.02 | -16.19% |
2021 | -โน269.68 | -49.52% |
2020 | -โน534.23 | 57.58% |
2019 | -โน339.03 | -28.26% |
2018 | -โน472.59 | -45.24% |
2017 | -โน862.98 | -33.86% |
2016 | -โน1,305 | -32.8% |
2015 | -โน1,942 | -13.7% |
2014 | -โน2,250 | 65.26% |
2013 | -โน1,361 | -25.35% |
2012 | -โน1,824 |